154 related articles for article (PubMed ID: 31696968)
1. Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors.
Elfeky SM; Sobahi TR; Gineinah MM; Ahmed NS
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900211. PubMed ID: 31696968
[TBL] [Abstract][Full Text] [Related]
2. Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.
Camacho ME; Chayah M; García ME; Fernández-Sáez N; Arias F; Gallo MA; Carrión MD
Arch Pharm (Weinheim); 2016 Aug; 349(8):638-50. PubMed ID: 27328401
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors.
Sánchez AI; Martínez-Barrasa V; Burgos C; Vaquero JJ; Alvarez-Builla J; Terricabras E; Segarra V
Bioorg Med Chem; 2013 Apr; 21(8):2370-2378. PubMed ID: 23454131
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors.
Menteşe E; Akyüz G; Yılmaz F; Baltaş N; Emirik M
Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800182. PubMed ID: 30375666
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
[TBL] [Abstract][Full Text] [Related]
6. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA.
Hrast M; Rožman K; Jukič M; Patin D; Gobec S; Sova M
Bioorg Med Chem Lett; 2017 Aug; 27(15):3529-3533. PubMed ID: 28579123
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and docking studies of bischalcones based quinazoline-2(1H)-ones and quinazoline-2(1H)-thiones derivatives as novel inhibitors of cathepsin B and cathepsin H.
Raghav N; Singh M
Eur J Pharm Sci; 2014 Apr; 54():28-39. PubMed ID: 24412851
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors.
Castaño T; Wang H; Campillo NE; Ballester S; González-García C; Hernández J; Pérez C; Cuenca J; Pérez-Castillo A; Martínez A; Huertas O; Gelpí JL; Luque FJ; Ke H; Gil C
ChemMedChem; 2009 May; 4(5):866-76. PubMed ID: 19350606
[TBL] [Abstract][Full Text] [Related]
10. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
Hejazi L; Rezaee E; Tabatabai SA
Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
[TBL] [Abstract][Full Text] [Related]
11. [Design, synthesis and biological evaluation of novel para-substituted 1-benzyl-quinazoline-2, 4 (1H, 3H)-diones as human PARP-1 inhibitors].
Yao HP; Zhu ZX; Ji M; Chen XG; Xu BL
Yao Xue Xue Bao; 2014 Apr; 49(4):497-503. PubMed ID: 24974467
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4(3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities.
Menteşe E; Akyüz G; Emirik M; Baltaş N
Bioorg Chem; 2019 Mar; 83():289-296. PubMed ID: 30391701
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Al-Gendy MA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1229-1239. PubMed ID: 28948843
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
15. Development of α-glucosidase inhibitors by room temperature C-C cross couplings of quinazolinones.
Garlapati R; Pottabathini N; Gurram V; Kasani KS; Gundla R; Thulluri C; Machiraju PK; Chaudhary AB; Addepally U; Dayam R; Chunduri VR; Patro B
Org Biomol Chem; 2013 Aug; 11(29):4778-91. PubMed ID: 23778751
[TBL] [Abstract][Full Text] [Related]
16. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT
Jankowska A; Satała G; Kołaczkowski M; Bucki A; Głuch-Lutwin M; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Lubelska A; Latacz G; Gawalska A; Bojarski AJ; Wyska E; Chłoń-Rzepa G
Eur J Med Chem; 2020 Sep; 201():112437. PubMed ID: 32673902
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors.
Gewald R; Rueger C; Grunwald C; Egerland U; Hoefgen N
Bioorg Med Chem Lett; 2011 Nov; 21(22):6652-6. PubMed ID: 21983442
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives.
Tokalı FS; Taslimi P; Demircioğlu İH; Karaman M; Gültekin MS; Şendil K; Gülçin İ
Arch Pharm (Weinheim); 2021 May; 354(5):e2000455. PubMed ID: 33537994
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
20. Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities.
Redondo M; Soteras I; Brea J; González-García A; Cadavid MI; Loza MI; Martinez A; Gil C; Campillo NE
Eur J Med Chem; 2013; 70():781-8. PubMed ID: 24239625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
